![Robert Kramer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Kramer
Directeur Technique/Scientifique/R&D chez
ALPHA COMPUTE CORP
Fortune : 1 189 $ au 30/04/2026
Profil
Robert Alan Kramer was the founder of SalvaRx Group Plc, founded in 2007, where the title held was Chief Scientific Officer.
Current jobs include Director at Phusis Therapeutics, Inc. since 2014, Director at iOx Therapeutics Ltd. since 2022, and Chief Scientific Officer at AlphaTON Capital Corp.
since 2019.
Former jobs include Head-Oncology Discovery Research at Janssen Pharmaceuticals, Inc., Head-Oncology Discovery Research at Bristol-Myers Squibb Pharmaceuticals Ltd., and Assistant Professor at Harvard Medical School.
Education includes a doctorate from the University of Vermont.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALPHA COMPUTE CORP 0,04% | 21/07/2025 | 5 038 ( 0,04% ) | 1 189 $ | 30/04/2026 |
Postes actifs de Robert Kramer
| Sociétés | Poste | Début |
|---|---|---|
| ALPHA COMPUTE CORP | Directeur Technique/Scientifique/R&D | 08/01/2019 |
Phusis Therapeutics, Inc.
 Phusis Therapeutics, Inc. BiotechnologyHealth Technology Develops novel targeted small molecule therapeutics | Directeur/Membre du Conseil | 05/05/2014 |
iOx Therapeutics Ltd.
 iOx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops liposomal iNKT agonists | Directeur/Membre du Conseil | 15/02/2022 |
Anciens postes connus de Robert Kramer
| Sociétés | Poste | Fin |
|---|---|---|
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Bristol-Myers Squibb Pharmaceuticals Ltd.
 Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | - |
| SALVARX GROUP PLC | Fondateur | - |
Formation de Robert Kramer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
8
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
AlphaTON Capital Corp.
 AlphaTON Capital Corp. BiotechnologyHealth Technology Operates as an immuno oncology company | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Phusis Therapeutics, Inc.
Phusis Therapeutics, Inc. BiotechnologyHealth Technology Develops novel targeted small molecule therapeutics | Health Technology |
iOx Therapeutics Ltd.
iOx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops liposomal iNKT agonists | Health Technology |
SalvaRx Group Plc
 SalvaRx Group Plc Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery and development company that focuses on immune-oncology & invests in novel cancer immune-therapies | Commercial Services |
